Categories News Press Releases Archives 2025 June May April March February January 2024 December November October September August July June May April March February January 2023 December November October September August July June April March February January 2022 December November October September August June May March February January 2021 December November October September August May April February Dec 01 Media Statement on levetiracetam (KEPPRA® and KEPPRA XR®) and DRESS Read More Share:| | | Oct 18 Evolving Expectations for Dermatological Conditions Read More Share:| | | Oct 17 Steadfast Towards Our Ambition to Create a UCB Rare Disease Portfolio Read More Share:| | | Sep 11 UCB PharmD Second-Year Fellows Share Reflections and Advice Read More Share:| | | Aug 03 Employee Spotlight: David Hornbaker’s Heart for Helping Patients Read More Share:| | | Aug 01 Evolving Expectations for Dermatological Conditions Read More Share:| | | Jun 27 Fulfilling Our Ambition to Deliver an FDA-Approved Treatment for People Living with Generalized Myasthenia Gravis Read More Share:| | | Jun 14 How UCB Is Supporting the Mental Health of Patients and Caregivers Read More Share:| | | Jun 14 Recognizing Ethical Leadership at UCB Read More Share:| | | Jun 02 Prioritizing Mental Health as a Caregiver to a Child With Dravet Syndrome Read More Share:| | | Pagination First page Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Next page Next › Last page